CNP Posts Its Best Week in Months as Analysts Pile In After Results

CenterPoint Energy has just delivered its sharpest weekly gain of the recent period, up 4.3% to $41.97, and the post-earnings analyst response tells most of the story.

The Street moved quickly after the print. TD Cowen and HSBC both initiated coverage this week with Buy ratings, putting targets at $47 and $44 respectively. Barclays raised its target from $41 to $43 on the day of results, though it held its Equal-Weight rating. Morgan Stanley also nudged its target up to $39, staying at Equal-Weight. The direction of travel is clear: bulls are building positions on the thesis, while the neutrals are playing catch-up on price. The consensus target has settled around $44.10, implying roughly 5% upside from current levels. BMO Capital and JP Morgan trimmed targets earlier in the month before the print, and the stock has since recovered past those levels, making those cuts look premature. Factor scores add colour: the analyst recommendation differential ranks in the 100th percentile, the strongest possible reading, while the dividend score registers at 94. Valuation sits at a P/E of 20.4x and EV/EBITDA of 11.0x, both up modestly over the past month as the price recovered.

Short positioning has shifted materially since the elevated levels flagged in notes earlier this month. The position peaked near 49.5 million shares in mid-October, the highest level in more than a year. It has since retreated to 47.8 million shares, or 7.3% of the free float, down 2.7% on the week. That partial unwind coincides with the price recovery and the post-earnings analyst upgrades. The borrow market remains completely relaxed: cost to borrow is 0.59%, up 13% on the week but still in the low range in absolute terms, and availability is 488% of shares already borrowed. There are roughly five shares available for every one currently borrowed. No squeeze pressure, no mechanical forced covering. The ORTEX short score has drifted down to 55.9 from a recent high above 56.8, consistent with the partial short reduction rather than a wholesale exit.

Options positioning is the most interesting divergence to flag this week, and it runs against the bullish price action. The put/call ratio jumped to 0.34 on the day of results, 3.5 standard deviations above its 20-day average of 0.19. Four sessions earlier, the ratio was 0.15, its lowest reading of the past year. That kind of reversal, from maximum call-heavy positioning to the highest put demand since September, in the space of four trading days, points to options traders hedging into the print rather than chasing the stock higher. The 52-week PCR high is 0.63, so the absolute level is not extreme, but the speed of the move is notable. It sits awkwardly alongside the analyst enthusiasm and price strength.

Wikipedia traffic adds a complementary data point on attention. The retail attention signal, which averages the z-scores of daily English Wikipedia views and daily distinct ORTEX stock page viewers, registered a z-score of 2.81 as of October 22. That is well above typical background levels for a regulated utility and confirms the print drew unusually broad attention.

On the ownership side, the institutional register is worth a brief note. Capital Research Global Investors filed a 13G showing a stake that had grown from 3.3% to 10.1% as of February. T. Rowe Price Investment Management filed a 13G/A in July showing a move from 8.9% to 10.2%. Both filings reflect passive, not activist, ownership, and the standard caveat applies: these stakes are as last disclosed around the 5% threshold, and a holder dropping below 5% may not file again. No 13D activist is on the register. The most recent open-market buy on record, a director purchasing 1,000 shares at $40.70 in August, is modest in size but sits below the current price, a small anchor.

The next print is scheduled for February 19, 2027, giving the Street four months to test whether the bear case, centred on slowing Houston load growth, the Ohio gas utility sale, and Texas political risk, is already in the price at current levels, or whether the 8% year-to-date weather-adjusted commercial and industrial sales growth that underpins the bull case can hold through the winter demand season.